Related references
Note: Only part of the references are listed.Managing generalized interferon-induced eruptions and the effectiveness of desensitization
C. Poreaux et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Adverse Events to Nontargeted and Targeted Chemotherapeutic Agents Emphasis on Hypersensitivity Responses
Brian A. Baldo et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2014)
Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery
Chadi A. Tannoury et al.
SPINE JOURNAL (2014)
Human Interferon Alpha-2b: A Therapeutic Protein for Cancer Treatment
Ratih Asmana Ningrum
SCIENTIFICA (2014)
Cardiovascular Toxicity of Epoetin-Alfa in Patients with Chronic Kidney Disease
Peter A. McCullough et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Safety and Effectiveness of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Fusion A Meta-analysis of Individual-Participant Data
Mark C. Simmonds et al.
ANNALS OF INTERNAL MEDICINE (2013)
Understanding, recognizing, and managing toxicities of targeted anticancer therapies
Grace K. Dy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
G. R. Foster et al.
JOURNAL OF VIRAL HEPATITIS (2013)
The Colony-Stimulating Factors and Cancer
Donald Metcalf
CANCER IMMUNOLOGY RESEARCH (2013)
Trial Watch Immunostimulatory cytokines
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2013)
Adverse events to monoclonal antibodies used for cancer therapy Focus on hypersensitivity responses
Brian A. Baldo
ONCOIMMUNOLOGY (2013)
Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus
Hiroaki Yagyu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Systemic lupus erythematosus induced by interferon ß1 therapy in a patient with multiple sclerosis
Dalila Mrabet Bahri et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2012)
The GM-CSF receptor family: Mechanism of activation and implications for disease
Timothy R. Hercus et al.
GROWTH FACTORS (2012)
Molecular engineering of antibodies for therapeutic and diagnostic purposes
Frederic Ducancel et al.
MABS (2012)
Pericardial effusion and tamponade following interferon alpha treatment for locally advanced melanoma
Jennifer Rauw et al.
MEDICAL ONCOLOGY (2012)
Does BMP-2 Really Cause Cancer? A Systematic Review of the Literature
Steven M. Koehler et al.
Spine Journal (2012)
Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study
Garet C. Comer et al.
SPINE JOURNAL (2012)
Recombinant human bone morphogenetic protein-2: adverse events reported to the Manufacturer and User Facility Device Experience database
Emily Jane Woo
SPINE JOURNAL (2012)
Trial Watch Immunostimulatory cytokines
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Erupção acneiforme aguda induzida por interferon beta-1b durante tratamento para esclerose múltipla
Dário Júnior de Freitas Rosa et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2011)
Optimizing Therapeutic Antibody Function Progress with Fc Domain Engineering
Etsuji Kaneko et al.
BIODRUGS (2011)
Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis - Case report
Cristina Popescu et al.
BMC GASTROENTEROLOGY (2011)
Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma
P. Thavendiranathan et al.
BRITISH JOURNAL OF RADIOLOGY (2011)
Bone Morphogenetic Proteins: A critical review
Beth Bragdon et al.
CELLULAR SIGNALLING (2011)
The Mechanism of Action of Interferon-beta in Relapsing Multiple Sclerosis
Bernd C. Kieseier
CNS DRUGS (2011)
Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis
Cristina Guijarro et al.
NEUROLOGICAL SCIENCES (2011)
A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned
Eugene J. Carragee et al.
SPINE JOURNAL (2011)
Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis C
Cheng-Shyong Chang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications
Theodore Kelesidis et al.
ANNALS OF INTERNAL MEDICINE (2010)
Peginterferon alpha-2b and Acute Allograft Failure in a Heart Transplant Recipient
Bing-Yen Wang et al.
ANNALS OF THORACIC SURGERY (2010)
Adverse effects of drugs in the treatment of viral hepatitis
Francesco Negro
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)
Use of White Blood Cell Growth Factors and Risk of Acute Myeloid Leukemia or Myelodysplastic Syndrome Among Elderly Patients With Non-Hodgkin Lymphoma
Stephen K. Gruschkus et al.
CANCER (2010)
Antibody-drug conjugates: targeted drug delivery for cancer
Stephen C. Alley et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin
Jacques Beltrand et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis
Joost Frans Swart et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
The safety and side effects of monoclonal antibodies
Trevor T. Hansel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Complications Related to Osteobiologics Use in Spine Surgery A Systematic Review
Thomas E. Mroz et al.
SPINE (2010)
Off-Label Use of Bone Morphogenetic Proteins in the United States Using Administrative Data
Kevin L. Ong et al.
SPINE (2010)
The colony-stimulating factors and cancer
Donald Metcalf
NATURE REVIEWS CANCER (2010)
Anaphylactic Reaction to Anakinra in a Rheumatoid Arthritis Patient Intolerant to Multiple Nonbiologic and Biologic Disease-Modifying Antirheumatic Drugs
Ditina Desai et al.
ANNALS OF PHARMACOTHERAPY (2009)
Repeated episodes of fixed eruption 3 months after discontinuing pegylated interferon-α-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection
M. Sato et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)
Cutaneous Vasculitis Associated With Interferon beta-1b Treatment for Multiple Sclerosis
Jarmila Szilasiova et al.
CLINICAL NEUROPHARMACOLOGY (2009)
Pegylated interferon alfa-2B induced lupus in a patient with chronic hepatitis B virus infection: case report
Sema Yilmaz et al.
CLINICAL RHEUMATOLOGY (2009)
Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?
Courtney D. Fitzhugh et al.
CYTOTHERAPY (2009)
Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin
Soraya de Mattos Camargo Grossmann et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Extremely acute exacerbation of interstitial pneumonia after interferon-alpha treatment for metastatic renal cell carcinoma
Satoshi Ando et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2009)
Prevalence, Complications, and Hospital Charges Associated With Use of Bone-Morphogenetic Proteins in Spinal Fusion Procedures
Kevin S. Cahill et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
BMP-7 (OP-1®) Safety in anterior cervical fusion surgery
John Leach et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
Lupus activation with cerebritis following pegylated interferon in a hemodialysis patient
Sanjay Kumar Agarwal et al.
NATURE REVIEWS NEPHROLOGY (2009)
Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy
Eric Ravussin et al.
OBESITY (2009)
The natural history of interferon-2b-induced thyroiditis and its exclusivity in a cohort of patients with chronic hepatitis C infection
H. A. Tran et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2009)
Recombinant Human Bone Morphogenetic Protein-2-Induced Radiculitis in Elective Minimally Invasive Transforaminal Lumbar Interbody Fusions A Series Review
Stefan A. Mindea et al.
SPINE (2009)
Ursodeoxycholic acid exacerbates peginterferon-induced interstitial pneumonia in a patient with hepatitis C
Rena Kaneko et al.
CLINICAL JOURNAL OF GASTROENTEROLOGY (2009)
Wells' cellulitis and bacterial necrotizing cellulitis induced by anakinra
M. Livory et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2008)
Mechanisms of leptin action and leptin resistance
Martin G. Myers et al.
ANNUAL REVIEW OF PHYSIOLOGY (2008)
XM02 is superior to placebo and equivalent to Neupogen™ in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy
A. del Giglio et al.
BMC CANCER (2008)
Raves and risks for erythropoietin
Kenneth Maiese et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Cytokines and anti-cytokines as therapeutics - An update
Vandana Tayal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C
Vincent Ho et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2008)
Interstitial granulomatous drug reaction to anakinra
Christie G. Regula et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts)
P. C. Bessa et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2008)
Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery)
P. C. Bessa et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2008)
Protein therapeutics: A summary and pharmacological classification
Benjamin Leader et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Epoetin-associated pure red cell aplasia: past, present, and future considerations
June M. McKoy et al.
TRANSFUSION (2008)
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease:: preliminary experience in France
T. Lequerre et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Reactivation of pulmonary tuberculosis in a patient with rheumatoid arthritis during treatment with IL-1 receptor antagonists (Anakinra)
Lucas D. Settas et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2007)
Interferon-beta - Mechanism of action and dosing issues
Clyde E. Markowitz
NEUROLOGY (2007)
Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis
N. Blijlevens et al.
ANNALS OF ONCOLOGY (2007)
Profound thrombocytopenia related to G-CSF
Jason C. Kovacic et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure - A randomized, double-blind, placebo-controlled trial
Piotr Ponikowski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Sweet's syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factor
Michael A. Thompson et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
R. M. Fleischmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Prognostic significance of autoimmunity during treatment of melanoma with interferon
H Gogas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Randomized, double-blind, active-controlled trial of every-3-week darbepoetin alfa for the treatment of chemotherapy-induced anemia
JL Canon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Cytokines and chemokines
JW Steinke et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Unusual extramedullary hematopoiesis in a patient receiving granulocyte colony-stimulating factor
Simten Dagdas et al.
ACTA HAEMATOLOGICA (2006)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
Mechanism of action of interferon and ribavirin in treatment of hepatitis C
JJ Feld et al.
NATURE (2005)
Significance of neutralizing antibodies to interferon beta during treatment of multiple sclerosis: expert opinions based on the Proceedings of an International Consensus Conference
HP Hartung et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: Evidence for an overlap between manic/hypomanic and depressive symptoms
A Constant et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Exacerbation of palmoplantar pustulosis by granulocyte colony-stimulating factor
I Kurokawa et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2005)
Bell's palsy associated with IFN-α and ribavirin therapy for hepatitis C virus infection
M Hoare et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2005)
Granulocyte colony-stimulating factor-induced capillary leak syndrome confirmed by extravascular lung water measurements
DH Deeren et al.
ANNALS OF HEMATOLOGY (2005)
New avenues of exploration for erythropoietin
K Maiese et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Neuropsychiatric adverse effects of interferon-alpha - Recognition and management
CL Raison et al.
CNS DRUGS (2005)
Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamicle, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study
MS Cairo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Gastrointestinal perforations associated with interleukin-2 administration
DM Heimann et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Maculopapular eruption with enlarged macrophages in eight patients receiving G-CSF or GM-CSF
S Alvarez-Ruiz et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2004)
Thyroid autoimmunity and dysfunction associated with type I interferon therapy
F Monzani et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2004)
Bell's palsy: A rare complication of interferon therapy for hepatitis C
I Hwang et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Pernicious anemia associated with interferon-α therapy and chronic hepatitis C infection
E Andrés et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Safety and efficacy of subcutaneous and continuous intravenous infusion rIL-2 in patients with metastatic renal cell carcinoma
PF Geertsen et al.
BRITISH JOURNAL OF CANCER (2004)
Aortitis after G-CSF injections
C Darie et al.
REVUE DE MEDECINE INTERNE (2004)
Acute respiratory failure after interferon-γ therapy in IPF
CRR Carvalho et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
G Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pure red-cell aplasia and epoetin therapy
CL Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection
D Seçkin et al.
PEDIATRIC DERMATOLOGY (2004)
A woman with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy
ME Fisher et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy
A Gordon et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Palifermin for oral mucositis after intensive therapy for hematologic cancers
R Spielberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia
S Wang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Sweet's syndrome associated with sargramostim (Granulocyte-macrophage colony stimulating factor) treatment
G Kumar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Fulminant bronchiolitis obliterans organizing pneumonia following 2 d of treatment with hydroxyurea, interferon-α and oral cytarabine ocfosfate for chronic myelogenous leukemia
G Kalambokis et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: Baseline characteristics and course during recombinant leptin therapy
ED Javor et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The design and development of pegfilgrastim (PEG-rmetHuG-CSF, neulasta((R)))
G Molineux
CURRENT PHARMACEUTICAL DESIGN (2004)
Rescue of interferon induced bone marrow aplasia in a patient with chronic myeloid leukemia by allogeneic bone marrow transplant
A Alabdulaaly et al.
LEUKEMIA & LYMPHOMA (2004)
Leptin hormonal kinetics in the fed state: Effects of adiposity, age, and gender on endogenous leptin production and clearance rates
SL Wong et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-α
M Schaefer et al.
BRAIN BEHAVIOR AND IMMUNITY (2004)
Restless legs syndrome due to interferon-α
JS LaRochelle et al.
MOVEMENT DISORDERS (2004)
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer
C Bokemeyer et al.
EUROPEAN JOURNAL OF CANCER (2004)
Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia
K Arimura et al.
ACTA HAEMATOLOGICA (2004)
Autoimmune thrombocytopenia in chronic myeloid leukemia treated with interferon-alpha: Differential diagnosis and possible pathogenesis
Y Herishanu et al.
LEUKEMIA & LYMPHOMA (2003)
Interferon-alpha-induced changes in tryptophan metabolism: Relationship to depression and paroxetine treatment
L Capuron et al.
BIOLOGICAL PSYCHIATRY (2003)
The cardiovascular effects of erythropoietin
KJ Smith et al.
CARDIOVASCULAR RESEARCH (2003)
No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes:: better outcome in patients with less proliferative disease
R Hast et al.
LEUKEMIA (2003)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Crohn disease worsened by anakinra administration
JD Carter et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2003)
Disseminated vascular papules in an nodeficient patient being treated with granulocyte colony-stimulating factor
JM Lenczowski et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Single-dose pharmacokinetics and tolerability of pegylated interferon-α2b in young and elderly healthy subjects
SK Gupta et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS
S Abi-Nassif et al.
CHEST (2003)
Circulating KL-6 level at baseline is a predictive indicator for the occurrence of interstitial pneumonia during interferon treatment for chronic hepatitis C
H Tokita et al.
HEPATOLOGY RESEARCH (2003)
Interferon-α and autoimmune thyroid disease
MF Prummel et al.
THYROID (2003)
Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy
MR Kraus et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Recurring cutaneous eruption in a patient with metastatic renal cell carcinoma being treated with high-dose interleukin 2
F O'Reilly et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Acute respiratory failure after interferon-γ therapy of end-stage pulmonary fibrosis
I Honoré et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis - A large, international, multicenter, placebo-controlled trial
RM Fleischmann et al.
ARTHRITIS AND RHEUMATISM (2003)
Withdrawal of interferon-α results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-α -: art. no. e10
N Ohashi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
A prospective study of neuropsychiatric symptoms associated with interferon-α-2b and ribavirin therapy for patients with chronic hepatitis C
E Dieperink et al.
PSYCHOSOMATICS (2003)
Multiple sclerosis, interferon beta and clinical thyroid dysfunction
A Kreisler et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Protein engineering 20 years on
JA Brannigan et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus
S Bonaccorso et al.
JOURNAL OF AFFECTIVE DISORDERS (2002)
Multiple sclerosis-like disease secondary to alpha interferon
T Matsuo et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2002)
A case of reversible dilated cardiomyopathy after α-interferon therapy in a patient with renal cell carcinoma
A Kuwata et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2002)
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C
A Soza et al.
HEPATOLOGY (2002)
Visual loss during interferon-alpha therapy in hepatitis C virus infection
G Perlemuter et al.
JOURNAL OF HEPATOLOGY (2002)
Leptin: a review of its peripheral actions and interactions
S Margetic et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
Acute onset of nephrotic syndrome during interferon-α retreatment for chronic active hepatitis C
S Nishimura et al.
JOURNAL OF GASTROENTEROLOGY (2002)
Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins
G Weber et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Alpha-interferon-associated thrombotic microangiopathy - A clinicopathologic study of 8 patients and review of the literature
J Zuber et al.
MEDICINE (2002)
Toxic epidermal necrolysis associated with interleukin-2
AAS Huerta et al.
ANNALS OF PHARMACOTHERAPY (2002)
Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: A case report and literature review
K Boonyapisit et al.
MUSCLE & NERVE (2002)
Paroxetine for the treatment of interferon-α-induced depression in chronic hepatitis C
MR Kraus et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Multiple sclerosis associated with interferon-alpha therapy for chronic myelogenous leukemia
I Kataoka et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
Anterior ischemic optic neuropathy caused by interferon alpha therapy
R Gupta et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Common features in the onset of ARDS after administration of granulocyte colony-stimulating factor
H Takatsuka et al.
CHEST (2002)
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
L Durelli et al.
LANCET (2002)
Sequential biochemotherapy versus chemotherapy for metastatic melanoma: Results from a phase III randomized trial
O Eton et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias
MH Freedman et al.
SEMINARS IN HEMATOLOGY (2002)
Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor
TE Cottle et al.
SEMINARS IN HEMATOLOGY (2002)
Increased depressive ratings in patients with hepatitis C receiving interferon-α-based immunotherapy are related to interferon-α-induced changes in the serotonergic system
S Bonaccorso et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C
P Hauser et al.
MOLECULAR PSYCHIATRY (2002)
Cutaneous mucinoses complicating interferon beta-1b therapy
J Benito-Leon et al.
EUROPEAN NEUROLOGY (2002)
Neutrophilic dermatoses in two children with idiopathic neutropenia: Association with granulocyte colony-stimulating factor (G-CSF) therapy
J Prendiville et al.
PEDIATRIC DERMATOLOGY (2001)
Side effects of interferon-α in treating hepatitis C virus infection
H Fontaine et al.
TRANSPLANTATION PROCEEDINGS (2001)
Development and characterization of novel erythropoiesis stimulating protein (NESP)
JC Egrie et al.
BRITISH JOURNAL OF CANCER (2001)
Molecular mechanisms of erythropoietin signaling
JY Cheung et al.
NEPHRON (2001)
Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis: A report and review of growth factor-induced pulmonary toxicity
MA Gertz et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2000)
Observation of an unexpected third receptor molecule in the crystal structure of human interferon-γ receptor complex
DJ Thiel et al.
STRUCTURE (2000)
Erythema exsudativum multiforme induced by granulocyte colony-stimulating factor in an allogeneic peripheral blood stem cell donor
T Mori et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
